clinical trial
The latest news about clinical trial: headlines, AI summaries and the full story from every source.
- Novo Nordisk's CagriSema Achieves Average Weight Loss of 25% in Women
- EyePoint Pharmaceuticals' Stock Drops Over 80% After Late-Stage Trial Failure
- Eli Lilly's Stock Unaffected by Viking Therapeutics' Strong Clinical Results
- Spyre Therapeutics (SYRE) Completes Monotherapy Phase in IBD Portfolio
- Monte Rosa Receives $50M Payment from Novartis for Phase 2 Trial Milestone
- Ultragenyx Reports Phase 3 Trial Failure for Apazunersen in Angelman Syndrome
- BioNTech Discontinues Mid-Stage Trial for Colorectal Cancer Vaccine
- Biotech Stocks Reach Post-Pandemic High Following Moderna's Trial Success
- Shareholders Sue Novo Nordisk Over Alleged Misrepresentation in Clinical Trial for Weight-Loss Drug
- Kimberly-Clark Launches New Product Safety Study
- Amplia Therapeutics and ANZGOG Announce Ovarian Cancer Clinical Study
- Erasca Shares Drop 48% After Patient Death in Early Cancer Drug Trial
- Nexalin Publishes Study on Neuroimaging Data Showing Brain-Network Effects and Clinical Improvement in Chronic Insomnia
- Nexalin Technology Advances Pivotal Clinical Trial for HALO™ Clarity Device
- Nektar Therapeutics Reports Positive Phase 2b Trial Results for Hair-Loss Drug, Driving Stock Higher
- Pulse Biosciences Enrolls First Patients in Pivotal Atrial Fibrillation Trial